Pegcetacoplan for the treatment of geographic atrophy secondary to age-related macular degeneration (OAKS and DERBY): two multicentre, randomised, double-masked, sham-controlled, phase 3 trials
Apellis Pharmaceuticals, Inc.
Jeffrey S Heier; Eleonora M Lad; Frank G Holz; Philip J Rosenfeld; Robyn H Guymer; David Boyer; Federico Grossi; Caroline R Baumal; Jean-Francois Korobelnik; Jason S Slakter; Nadia K Waheed; Ravi Metlapally; Ian Pearce; Nathan Steinle; Anibal A Francone; Allen Hu; David R Lally; Pascal Deschatelets; Cedric Francois; Caleb Bliss; Giovanni Staurenghi; Jordi Monés; Rishi P Singh; Ramiro Ribeiro; Charles C Wykoff; OAKS and DERBY study investigators